VanHimbergen Robert M
Transaction: 07/24/2026
BUY
Change
—
Price
Not reported
Filing
07/28/2026
Type
BUY
Elanco Animal Health Incorporated
ELAN • Drug Manufacturers - Specialty & Generic
$24.50
▲ +0.09 (+0.35%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$12.09B
Growth
1.5%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 0.57Consistent free cash flow · 5/5Manageable debt level · 0.61Healthy liquidity · 2.17Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:29 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$24.50
Change0.35%
Market Cap$12.09B
52W Range15.50 - 27.98
Beta1.69
Gross Margin43.48%
Oper. Margin5.34%
Profit Margin-4.92%
Debt/Eq0.61
Current Ratio2.17
Quick Ratio1.08
Revenue 5Y1.52%
Price$24.50
Change0.35%
Market Cap$12.09B
52W Range15.50 - 27.98
Beta1.69
Gross Margin43.48%
Oper. Margin5.34%
Profit Margin-4.92%
Debt/Eq0.61
Current Ratio2.17
Quick Ratio1.08
Revenue 5Y1.52%
Target$28.67
Target Upside17.02%
Target Median$30.00
Target Range26.00 - 30.00
Volume17.14M
Avg Volume5.77M
EPS Surprise0.06
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
67/100
Growth Potential
Revenue and expansion
25/100
Price Attractiveness
Cheap or expensive today
62/100
Why this score▼
Positive free cash flow · 0.57Consistent free cash flow · 5/5Manageable debt level · 0.61Healthy liquidity · 2.17Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$26.00
Mean
$28.67
Median
$30.00
High
$30.00
Insider Transactions
Recent executive and insider activity
Modi Rajeev A.
Transaction: 07/24/2026
BUY
Change
—
Price
Not reported
Filing
07/28/2026
Type
BUY
Simmons Jeffrey N
Transaction: 07/24/2026
BUY
Change
—
Price
Not reported
Filing
07/28/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| VanHimbergen Robert M | BUY | — | Not reported | 07/24/2026 | 07/28/2026 |
| Modi Rajeev A. | BUY | — | Not reported | 07/24/2026 | 07/28/2026 |
| Simmons Jeffrey N | BUY | — | Not reported | 07/24/2026 | 07/28/2026 |
| Modi Rajeev A. | BUY | — | Not reported | 07/10/2026 | 07/14/2026 |
| VanHimbergen Robert M | BUY | — | Not reported | 07/10/2026 | 07/14/2026 |
| Simmons Jeffrey N | BUY | — | Not reported | 07/10/2026 | 07/14/2026 |
| VanHimbergen Robert M | SELL | -15,336 | $24.64 | 07/07/2026 | 07/09/2026 |
| Kinard David S | BUY | +25,620 | $24.09 | 07/01/2026 | 07/02/2026 |
| Anand Kapila K | BUY | — | Not reported | 06/30/2026 | 07/02/2026 |
| VanHimbergen Robert M | BUY | — | Not reported | 06/26/2026 | 06/30/2026 |
| Simmons Jeffrey N | BUY | — | Not reported | 06/26/2026 | 06/30/2026 |
| Modi Rajeev A. | BUY | — | Not reported | 06/26/2026 | 06/30/2026 |
| Modi Rajeev A. | BUY | — | Not reported | 06/12/2026 | 06/16/2026 |
| Simmons Jeffrey N | BUY | — | Not reported | 06/12/2026 | 06/16/2026 |
| VanHimbergen Robert M | BUY | — | Not reported | 06/12/2026 | 06/16/2026 |
| Simmons Jeffrey N | BUY | — | Not reported | 05/29/2026 | 06/02/2026 |
| Modi Rajeev A. | BUY | — | Not reported | 05/29/2026 | 06/02/2026 |
| VanHimbergen Robert M | BUY | — | Not reported | 05/29/2026 | 06/02/2026 |
| GARCIA ART A | BUY | +4,678 | Not reported | 05/21/2026 | 05/26/2026 |
| Ma Stacey | BUY | +4,678 | Not reported | 05/21/2026 | 05/26/2026 |